Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting

Posted On August 8, 2023 / By / Posted in Blog

Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD, recently presented at the 41st Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) held in Seattle. ASRS is the largest organization of

read more
Posted On August 4, 2023 / By / Posted in Blog

New Patient Portal System

Texas Retina Associates is in the process of transitioning to a new and improved patient portal system that will go live on Wednesday, August 9, 2023. This secure portal will provide you

read more
Posted On July 12, 2023 / By / Posted in Blog

What is an Optical Coherence Tomography (OCT) Test?

Optical coherence tomography (OCT) is a non-invasive diagnostic imaging test similar to a computed tomography (CT) scan that allows your retina specialist to clearly see the retina and carefully map and measure

read more
Posted On June 21, 2023 / By / Posted in Blog

June is Fireworks Eye Safety Awareness Month

By Ivan Castillo, MD Summer is here, and for many that means outdoor celebrations that include fireworks, especially around the 4th of July. Unfortunately, this also means an increase in eye injuries.

read more
Posted On June 13, 2023 / By / Posted in Blog

11 Tips to Protect Men’s Eye Health

June is Men’s Health Month. It was established to help bring awareness to health issues men face and to encourage them to take charge of their health. A number of retinal diseases can affect

read more
Posted On June 7, 2023 / By / Posted in Blog

Texas Retina Associates First in U.S. to Dose a Patient in the Phase 2 SIGLEC Trial

On June 1, 2023, Ashkan Abbey, MD, dosed the first patient in the Phase II SIGLEC Trial, a clinical study evaluating AVD-104, a potential new treatment for geographic atrophy (GA) from age-related

read more
Posted On May 31, 2023 / By / Posted in Blog

Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology

Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human

read more
Posted On May 23, 2023 / By / Posted in Blog

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in

read more
Posted On May 19, 2023 / By / Posted in Blog

Dr. Wang Participated in Roundtable Discussion on XIPERE Treatment for Macular Edema Associated with Uveitis

At the most recent American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, Texas Retina Associates’ Robert Wang, MD, participated in a roundtable discussion with seven other retina specialists to share their

read more
Posted On May 16, 2023 / By / Posted in Blog

Getting to Know Ocular Oncologist Timothy S. Fuller, MD

May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates,

read more